U.S. flag

An official website of the United States government

Format
Items per page
Sort by

    Send to:

    Choose Destination

    Links from GEO DataSets

    Items: 20

    1.
    Full record GDS3795

    Myelodysplastic syndrome: CD34+ hematopoietic stem cells

    Analysis of bone marrow CD34+ hematopoietic stem cells of myelodysplastic syndrome (MDS) patients. MDS is a group of clonal hematopoietic stem cell malignancies characterized by ineffective hematopoiesis. Results provide insight into the molecular pathogenesis of MDS.
    Organism:
    Homo sapiens
    Type:
    Expression profiling by array, count, 2 disease state, 5 specimen sets
    Platform:
    GPL570
    Series:
    GSE19429
    200 Samples
    Download data: CEL
    2.

    Expression data from bone marrow CD34+ cells of MDS patients and healthy controls

    (Submitter supplied) In order to gain insight into the molecular pathogenesis of the myelodysplastic syndromes (MDS), we performed global gene expression profiling and pathway analysis on the hematopoietic stem cells (HSC) of 183 MDS patients as compared with the HSC of 17 healthy controls. The most significantly deregulated pathways in MDS include interferon signaling, thrombopoietin signaling and the Wnt pathway. Among the most significantly deregulated gene pathways in early MDS are immunodeficiency, apoptosis and chemokine signaling, whereas advanced MDS is characterized by deregulation of DNA damage response and checkpoint pathways. more...
    Organism:
    Homo sapiens
    Type:
    Expression profiling by array
    Dataset:
    GDS3795
    Platform:
    GPL570
    200 Samples
    Download data: CEL
    Series
    Accession:
    GSE19429
    ID:
    200019429
    3.

    ABT-737 treatment induces regulation and activation of pathways implicated in cell survival, proliferation and stem cells in treated AML mice survival, proliferation and stem cells in treated AML mice

    (Submitter supplied) Myelodysplastic syndrome (MDS) transforms into an acute myelogenous leukemia (AML) with associated increased bone marrow blast infiltration. Using a transgenic mouse model, MRP8[NRASD12/hBCL-2], in which the NRAS:BCL-2 complex at the mitochondria induces MDS progressing to AML with dysplastic features, we studied the therapeutic potential of a BCL-2 homology domain 3 (BH3) mimetic inhibitor, ABT-737. more...
    Organism:
    Mus musculus
    Type:
    Expression profiling by array
    Platform:
    GPL6096
    6 Samples
    Download data: CEL
    Series
    Accession:
    GSE48601
    ID:
    200048601
    4.

    Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes.

    (Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
    Organism:
    Homo sapiens
    Type:
    Expression profiling by array; Methylation profiling by genome tiling array
    Platforms:
    GPL16100 GPL2040
    45 Samples
    Download data: CEL, GPR
    Series
    Accession:
    GSE41216
    ID:
    200041216
    5.

    Methylation profiling of Low-Risk Myelodysplastic Syndromes (MDSs)

    (Submitter supplied) Genome-wide expression and methylation profiling identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes (MDSs). Gene expression profiling signatures may be used to classify the subtypes of Myelodysplastic syndrome (MDS) patients. However, there are few reports on the global methylation status in MDS. The integration of genome-wide epigenetic regulatory marks with gene expression levels would provide additional information regarding the biological differences between MDS and healthy controls. more...
    Organism:
    Homo sapiens
    Type:
    Methylation profiling by genome tiling array
    Platform:
    GPL2040
    20 Samples
    Download data: GPR
    Series
    Accession:
    GSE41215
    ID:
    200041215
    6.

    Expression profiling of Low-Risk Myelodysplastic Syndromes (MDSs)

    (Submitter supplied) Genome-wide expression and methylation profiling identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes (MDSs). Gene expression profiling signatures may be used to classify the subtypes of Myelodysplastic syndrome (MDS) patients. However, there are few reports on the global methylation status in MDS. The integration of genome-wide epigenetic regulatory marks with gene expression levels would provide additional information regarding the biological differences between MDS and healthy controls. more...
    Organism:
    Homo sapiens
    Type:
    Expression profiling by array
    Platform:
    GPL16100
    25 Samples
    Download data: CEL
    Series
    Accession:
    GSE41130
    ID:
    200041130
    7.

    Differential Gene Expression Profiles in CD34+ Myelodysplastic Syndrome Marrow cells to Disease Subtype and Progression

    (Submitter supplied) Microarray analysis with 40,000 cDNA gene chip arrays determined differential gene expression profiles (GEPs) in CD34+ marrow cells from myelodysplastic syndrome (MDS) patients compared to normal individuals. Using focused bioinformatics analyses, we found 1175 genes significantly differentially expressed by MDS vs Normal, requiring a minimum of 39 genes to separately classify these patients. Major GEP differences were demonstrated between Normal and MDS patients and between several MDS subgroups: (1) those whose disease remained stable (sMDS) and those who subsequently transformed (tMDS) to acute myeloid leukemia (AML); (2) between del(5q) and other MDS patients. more...
    Organism:
    Homo sapiens
    Type:
    Expression profiling by array
    Platform:
    GPL9335
    41 Samples
    Download data: TXT
    Series
    Accession:
    GSE18366
    ID:
    200018366
    8.

    Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine

    (Submitter supplied) Epigenetic mechanisms contribute to deregulated gene expression of hematopoietic progenitors in Myelodysplastic Syndromes (MDS). Hypomethylating agents are able to improve peripheral cytopenias in MDS patients. To identify critical gene expression changes induced by hypomethylating agents, we analyzed gene expression profiling (GEP) of myelodysplastic and normal CD34+ hematopoietic stem cells treated in vitro with or without decitabine. more...
    Organism:
    Homo sapiens
    Type:
    Expression profiling by array
    Platform:
    GPL96
    30 Samples
    Download data: CEL
    Series
    Accession:
    GSE19610
    ID:
    200019610
    9.

    Precise Delination of 5q-Breakpoints and Detection of Hidden Aberrations in patients with MDS using Array CGH

    (Submitter supplied) Isolated deletions of the long arm of chromosome 5 (del(5q)) are observed in 10% of myelodysplastic syndromes (MDS) and are associated with a more favorable prognosis, although the clinical course varies considerably. If one or more additional chromosomal aberration/s are present this correlates with a significant shorter overall survival. To assess the frequency of hidden abnormalities in cases with an isolated cytogenetic del(5q), we have performed a genome wide high resolution 44K 60mer oligonucleotide array CGH study using DNA from bone marrow cells of 12 MDS and one AML patient. more...
    Organism:
    Homo sapiens
    Type:
    Genome variation profiling by genome tiling array
    Platforms:
    GPL2873 GPL2879
    13 Samples
    Download data: TXT
    Series
    Accession:
    GSE8804
    ID:
    200008804
    10.

    Gene expression profile of H187-63AR, an ABT-737 resistant derivative of H187

    (Submitter supplied) ABT-737 is a highly potent small molecule inhibitor of Bcl-2 which has demonstrated efficacy in preclinical studies. To identify factors which mediate ABT-737 sensitivity we created an ABT-737-resistant cell line derivative. This cell lines maintained its ABT-737 resistance in vitro and in vivo. We isolated RNA from H187-63AR xenografts and compared their global gene expression to H187 xenografts. more...
    Organism:
    Homo sapiens
    Type:
    Expression profiling by array
    Platform:
    GPL6104
    4 Samples
    Download data: TXT
    Series
    Accession:
    GSE10003
    ID:
    200010003
    11.

    The Apcmin mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS

    (Submitter supplied) Apc, a negative regulator of the canonical Wnt signaling pathway, is a bona-fide tumor suppressor whose loss of function results in intestinal polyposis. APC is located in a commonly deleted region on human chromosome 5q, associated with myelodysplastic syndrome (MDS) suggesting that haploinsufficiency of APC contributes to the MDS phenotype. Analysis of the hematopoietic system of mice with the Apcmin allele that results in a premature stop codon and loss of function, showed no abnormality in steady state hematopoiesis. more...
    Organism:
    Mus musculus
    Type:
    Expression profiling by array
    Platform:
    GPL1261
    6 Samples
    Download data: CEL
    Series
    Accession:
    GSE20352
    ID:
    200020352
    12.

    Gene expression profiling of AML

    (Submitter supplied) AML/MDS patients carrying 11q amplifications involving the mixed lineage leukemia gene (MLL) locus are characterized by a later onset, a complex aberrant karyotype (CAK) frequently including deletions within 5q, 17p and 7q, as well as fast progression of the disease with extremely poor prognosis. We and other have shown that the MLL gene is over expressed in amplified cases, however, in most of the cases the amplified region is not restricted to the MLL locus. more...
    Organism:
    Homo sapiens
    Type:
    Expression profiling by array
    Platform:
    GPL570
    15 Samples
    Download data: CEL
    Series
    Accession:
    GSE10258
    ID:
    200010258
    13.

    Analysis of AML/MDS patients with 11q/MLL amplification

    (Submitter supplied) AML/MDS patients carrying 11q amplifications involving the mixed lineage leukemia gene (MLL) locus are characterized by a complex aberrant karyotype (CAK) frequently including deletions within 5q, 17p and 7q, a later onset and fast progression of the disease with extremely poor prognosis. We and others have shown that the MLL gene is overexpressed in amplified cases; however, in most of the cases the amplified region is not restricted to the MLL locus. more...
    Organism:
    Homo sapiens
    Type:
    Genome variation profiling by genome tiling array
    Platform:
    GPL5000
    12 Samples
    Download data: GPR
    Series
    Accession:
    GSE9928
    ID:
    200009928
    14.

    Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene network

    (Submitter supplied) Chromosome 5q deletions (del(5q)) are common in high-risk (HR) Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML); however, the gene regulatory networks that sustain these aggressive diseases are unknown. Reduced miR-146a expression in del(5q) HR-MDS/AML and miR-146a-/- hematopoietic stem/progenitor cells (HSPC) results in TRAF6/NF-κΒ activation. Increased survival and proliferation of HSPC from miR-146alow HR-MDS/AML is sustained by a neighboring haploid gene, SQSTM1 (p62), expressed from the intact 5q allele. more...
    Organism:
    Homo sapiens
    Type:
    Expression profiling by array
    Platform:
    GPL6244
    9 Samples
    Download data: CEL
    Series
    Accession:
    GSE60649
    ID:
    200060649
    15.

    NHD13 vs wild type LK cells

    (Submitter supplied) Investigation of differences in gene expression between NHD13 mice with myelodysplastic syndrome and wild type littermates.
    Organism:
    Mus musculus
    Type:
    Expression profiling by array
    Platform:
    GPL6887
    6 Samples
    Download data: TXT
    Series
    Accession:
    GSE39692
    ID:
    200039692
    16.

    Understanding Early Stage Myelodysplastic Syndrome Pathobiology

    (Submitter supplied) Delineating key HSC regulators is of significant interest for informing the treatment of hematologic malignancy. While HSC activity is enhanced by overexpression of SKI, the transforming growth factor-beta (TGFβ) signaling antagonist corepressor, its requirement in HSC is unknown. Here we reveal a profound defect in Ski-/- HSC fitness but not specification. Transcriptionally, Ski-/- HSC exhibited striking upregulation of TGFb superfamily signaling and splicing alterations. more...
    Organism:
    Mus musculus
    Type:
    Expression profiling by high throughput sequencing
    Platform:
    GPL17021
    94 Samples
    Download data: TXT
    Series
    Accession:
    GSE115903
    ID:
    200115903
    17.

    Myelodysplastic syndrome: NUP98-HoxD13 (NHD13) expression effect on hematopoietic stem cells

    (Submitter supplied) Analysis of Lin-c-Kit+Sca-1- haematopoietic stem cells (HSCs) expressing the Nup98-HoxD13 (NHD13) fusion gene. NHD13 induces myelodysplastic syndrome (MDS) in mice. Results provide insight into the molecular basis of the myelodysplastic phenotype
    Organism:
    Mus musculus
    Type:
    Expression profiling by high throughput sequencing
    Platform:
    GPL13112
    6 Samples
    Download data: TSV
    Series
    Accession:
    GSE66264
    ID:
    200066264
    18.

    Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets

    (Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
    Organism:
    Homo sapiens
    Type:
    Expression profiling by high throughput sequencing
    Platform:
    GPL16791
    12 Samples
    Download data
    Series
    Accession:
    GSE118378
    ID:
    200118378
    19.

    The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS).

    (Submitter supplied) Monosomy 7 or deletion of 7q (del(7q)) frequently arise in inherited and acquired bone marrow failure, and are associated with progression to high grade Myelodysplastic Syndrome (MDS) and acute leukemia. Current non-transplant approaches to treat marrow failure may be complicated by potential stimulation of clonal outgrowth. To study the biological consequences of del(7q) within the context of a failing marrow, we utilized induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS) and genomically engineered a deletion of (7q). more...
    Organism:
    Homo sapiens
    Type:
    Expression profiling by high throughput sequencing
    Platform:
    GPL16791
    6 Samples
    Download data: TXT
    20.

    The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS).

    (Submitter supplied) Monosomy 7 or deletion of 7q (del(7q)) frequently arise in inherited and acquired bone marrow failure, and are associated with progression to high grade Myelodysplastic Syndrome (MDS) and acute leukemia. Current non-transplant approaches to treat marrow failure may be complicated by potential stimulation of clonal outgrowth. To study the biological consequences of del(7q) within the context of a failing marrow, we utilized induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS) and genomically engineered a deletion of (7q). more...
    Organism:
    Homo sapiens
    Type:
    Expression profiling by high throughput sequencing
    Platform:
    GPL16791
    6 Samples
    Download data: TXT
    Format
    Items per page
    Sort by

      Send to:

      Choose Destination

      Supplemental Content

      db=gds|term=|query=1|qty=3|blobid=MCID_672aefe81e37ea1d715a4e75|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
         Taxonomic Groups  [List]
      Tree placeholder
          Top Organisms  [Tree]

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Support Center